Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

After Actavis Generic Drug Recall, CEO Steps Down

Filed August 6th, 2008 amy

Following the announcement of the big , the company announced that Robert Wessman has stepped down as CEO “to put greater focus on his investment company Salt Investments,” the company’s press release stated. Wessman will continue to serve on the Actavis Board of Directors. The new Chief Executive Officer is Sigurdur Oli Olafsson, former Deputy CEO.

Sigurdur Oli Olafsson, the new CEO of Actavis Group, said, “Actavis is currently in a strong position among the top five generic pharmaceutical companies in the world. It is important to continue the remarkable Actavis growth story, so the position at the helm is an enormous responsibility to assume. I’m ready for the challenge and look forward to continuing work with our 11-thousand employees on the continued success of the Group. Demand for generic pharmaceuticals is on the rise globally, independent of economic cycles. The development of new generic pharmaceuticals is among Actavis’ major strengths and I consider it one of our top priorities to use it to further strengthen our position in our key markets in Europe, North-America and Asia.”

The press release did not address drug safety concerns.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!